Today, the FDA approved telapravir for Hep C. That’s happy news at Vertex (and Merck last week) but an all-too-rare story of new drugs meeting significant human health needs.
More like this, please.
Today, the FDA approved telapravir for Hep C. That’s happy news at Vertex (and Merck last week) but an all-too-rare story of new drugs meeting significant human health needs.
More like this, please.
Work posted here under copyright © of the authors • Details on the Site Policies page
